Form 4: Director Jennifer Baird Acquires SeaStar Medical Stock

Director Jennifer A. Baird acquired 4,000 restricted stock units of SeaStar Medical Holding Corp. on July 1, 2026, with full vesting expected on July 1, 2027.

Summary

• Director Jennifer A. Baird acquired 4,000 restricted stock units (RSUs) of SeaStar Medical Holding Corp. on July 1, 2026.
• These RSUs are valued at $0 and are scheduled to vest in full on July 1, 2027.
• Following this transaction, Ms. Baird beneficially owns 10,620 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard insider stock unit acquisition and vesting schedule rather than a significant new development or financial event.

Positives

• Director acquisition of stock units can signal confidence in the company's future prospects.
• The acquisition of 4,000 RSUs indicates a commitment from a key insider.

Future Outlook

The restricted stock units acquired by Director Jennifer A. Baird are set to vest in full on July 1, 2027, indicating a future potential increase in her direct beneficial ownership.

Industry Context

StockSavvy.ai notes that insider transactions, such as this acquisition of restricted stock units by a director, are common in the biotechnology and medical device sectors as a means of executive compensation and aligning management interests with shareholders.

Stakeholder Impact

• Shareholders: The acquisition by a director may be viewed positively as a sign of commitment, but it does not immediately alter the company's financial position or share structure.

Next Steps

• Vesting of 4,000 restricted stock units on July 1, 2027.

Key Dates

Keywords

SeaStar Medical Holding Corp, ICU, Form 4, Insider Transaction, Restricted Stock Units, Jennifer A. Baird, Beneficial Ownership